Antigen specificity of immune suppression by myeloid-derived suppressor cells
- PMID: 21486906
- DOI: 10.1189/jlb.0111021
Antigen specificity of immune suppression by myeloid-derived suppressor cells
Abstract
Among the mechanisms set in motion by the tumor to escape the control of the immune system, MDSCs play a central role in inducing tolerance to a variety of anti-tumor effectors, including T lymphocytes. It has been demonstrated that MDSCs expand in tumor-bearing mice and in cancer patients, leading to an impairment of T cell reactivity against the tumor. However, as the presence of MDSCs is not correlated with a general immune suppression, it was advanced that a mechanism regulating the specificity of MDSC inhibition must be present. In this article, we review the literature showing that MDSCs exert their immune-suppressive function on Ag-specific T cell responses but at times, also on mitogen-activated T lymphocytes, therefore bypassing the Ag dependency. We propose that the features of MDSC-mediated immune suppression might be influenced not only by the specific microenvironment in which MDSCs expand and by the tumor characteristics but also by the levels of activation of the target lymphocytes.
Similar articles
-
Amino acid metabolism related to immune tolerance by MDSCs.Int Rev Immunol. 2012 Jun;31(3):177-83. doi: 10.3109/08830185.2012.679989. Int Rev Immunol. 2012. PMID: 22587019 Review.
-
Myeloid derived suppressor cells and their role in tolerance induction in cancer.J Dermatol Sci. 2010 Jul;59(1):1-6. doi: 10.1016/j.jdermsci.2010.05.001. J Dermatol Sci. 2010. PMID: 20570112 Review.
-
Myeloid-derived suppressor cell activation by combined LPS and IFN-gamma treatment impairs DC development.Eur J Immunol. 2009 Oct;39(10):2865-76. doi: 10.1002/eji.200939486. Eur J Immunol. 2009. PMID: 19637228
-
Tumor-induced tolerance and immune suppression by myeloid derived suppressor cells.Immunol Rev. 2008 Apr;222:162-79. doi: 10.1111/j.1600-065X.2008.00602.x. Immunol Rev. 2008. PMID: 18364001 Review.
-
Myeloid-derived suppressor cell role in tumor-related inflammation.Cancer Lett. 2008 Aug 28;267(2):216-25. doi: 10.1016/j.canlet.2008.03.012. Epub 2008 Apr 22. Cancer Lett. 2008. PMID: 18433992 Review.
Cited by
-
Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling.Cancer Res. 2012 Feb 15;72(4):928-38. doi: 10.1158/0008-5472.CAN-11-2863. Epub 2012 Jan 11. Cancer Res. 2012. PMID: 22237629 Free PMC article.
-
Genetics and biology of prostate cancer.Genes Dev. 2018 Sep 1;32(17-18):1105-1140. doi: 10.1101/gad.315739.118. Genes Dev. 2018. PMID: 30181359 Free PMC article. Review.
-
Myeloid-derived suppressor cells adhere to physiologic STAT3- vs STAT5-dependent hematopoietic programming, establishing diverse tumor-mediated mechanisms of immunologic escape.Immunol Invest. 2012;41(6-7):680-710. doi: 10.3109/08820139.2012.703745. Immunol Invest. 2012. PMID: 23017141 Free PMC article. Review.
-
One checkpoint may hide another: inhibiting the TGFβ signaling pathway enhances immune checkpoint blockade.Hepatobiliary Surg Nutr. 2019 Jun;8(3):289-294. doi: 10.21037/hbsn.2019.01.10. Hepatobiliary Surg Nutr. 2019. PMID: 31245417 Free PMC article. No abstract available.
-
Tumor immune microenvironment in head and neck cancers.Mol Carcinog. 2020 Jul;59(7):766-774. doi: 10.1002/mc.23162. Epub 2020 Feb 3. Mol Carcinog. 2020. PMID: 32017286 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources